PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety…

Randomized controlled trials of radiation therapy for cutaneous malignancies: a systematic review.
Sean S Mahase, Joseph Miccio, Marina Chilov +3
Clinical and translational radiation oncology14 Oct 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
Efficacy of sodium-glucose cotransporter-2 inhibitors on functional mitral regurgitation associated with heart failure: a systematic review and meta-analysis of randomized controlled trials
Charlie Kajo, Ahmed J. Alaraibi, Osama T. Almutairi +9
Frontiers in Cardiovascular Medicine21 Oct 2026Peer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefPMC
Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy ± bevacizumab for recurrent or metastatic cervical cancer: a systematic review and meta-analysis of randomized controlled trials
Raoshan Luo, Minghong Li, Li Ma +1
Frontiers in Immunology19 Oct 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMCPMCEurope PMC
Cardiac Myosin Inhibitors in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-analysis of Randomized Controlled Trials
J. Koelemen, D. Koeckerling, S. Rosskopf +6
medRxiv8 Sep 2026PreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials
Yi-Xuan Li, Jason A. Roberts, Mohd Abdul-Aziz +1
Antimicrobial Agents and Chemotherapy19 Oct 2026Peer-reviewedCC BY 4.0Full text2 citedPharmacology & toxicologyHAL

Cite

BibTeX

@article{morice2026parp,
  title = {{PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials}},
  author = {P.-M. Morice and I. Ray-Coquard and K.N. Moore and V. Diéras and J. Alexandre},
  journal = {Annals of Oncology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.annonc.2021.04.023},
  url = {https://hal.science/hal-05742768v1},
}

RIS

TY  - JOUR
TI  - PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trials
AU  - P.-M. Morice
AU  - I. Ray-Coquard
AU  - K.N. Moore
AU  - V. Diéras
AU  - J. Alexandre
PY  - 2026
DA  - 2026/09/08
JO  - Annals of Oncology
DO  - 10.1016/j.annonc.2021.04.023
UR  - https://hal.science/hal-05742768v1
SN  - 0923-7534
SN  - 1569-8041
ER  -

Related

Cite